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Impact of Raw Materials on Sialyation for a Therapeutic Protein 
Wei-Chen Hung, Jessica Kennedy, Loray Paul, John Mavrianos, Bridget Leslie, Mei Shao 
Alexion Pharmaceuticals, Inc., New Haven, CT, USA 
 ABSTRACT 
Total sialic acid content (TSAC) is a critical product quality attribute (CQA) for a 
therapeutic protein.  By employing several statistical tools, we are able to 
identify certain lots of commercial culture media that cause differential levels of 
TSAC. Furthermore, we have identified several key components and their 
impact are evaluated in small scale production bioreactors. Overall this study 
provides the insight of understanding better control of product quality and 
establishes a methodology for identifying the root causes in cell culture media 
contributing to the variability of cell performance.  
BACKGROUND 
Total sialic acid content (TSAC) is a critical product quality attribute (CQA) for a 
therapeutic Protein manufactured by Alexion.  
1. Sialic acid is a generic term for the N- or O-substituted derivatives 
of neuraminic acid, a monosaccharide with a nine-carbon backbone. 
2. The synthesis/modification is mainly distributed in endoplasmic reticulum 
or the Golgi apparatus (Figure 1) 
3. It must be tightly controlled for the bulk drug substance (BDS). 
4. Study results conducted by Alexion have suggested lot-to-lot variability of 
commercial cell culture media have potential effects on total sialic acid 
content (TSAC) at cell culture fluid (CCF) and harvested cell culture fluid 
(HCCF) steps.  
5. Cell culture media, as used in this pipeline, is not chemically well defined, 
and is composed of wide array of unknown components.  
CONCLUSIONS 
1. Continue evaluating top candidates determined by PCA or MVA in small 
scale studies.  
2. Concentration and synergetic effects between validated factors should 
be carefully evaluated.     
3. Provide feedback and  establish collaboration with vendor to improve 




Figure 8:  Day 7 and Day 10 TSAC results of duplicate spiking 
experiments  in comparison with controls.  
Figure 2: TSAC trending in manufacturing process 
FUTURE WORK 
1. Raw material lot-to-lot variability could impact cell culture 
performance and TSAC levels. 
2. Including levels of trace metals, vitamins,  and amino acids in PCA 
allows us to identify manufacturing differences of media lots.  
3. PCA provides a contribution ranking of each component for further 
evaluation. 
4. Small-scale studies were performed and a potential root cause was 
identified .  
 
p = 0.045 
NS p < 0.001 
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Used in MFG 
TSAC level  in 
MFG 
AB-1 I 2016     
AB-2 I 2016     
AB-3  I 2016     
AB-4 I  2016 √ 
AB-5 I 2016 √ 
AC-1 II Mar17 √ 
AC-2 II Mar17 √ 
AC-3 II Mar17 √ 
AC-4 III Apr17 √ 
AC-5 III Apr17 √ 
AC-6 III Apr17 √ 
AC-7 III May17 √ 
AC-8 III Aug17 √ 
AC-9 III Aug17 √ 
AC-10 Sep17     
AC-11 Nov17     
AC-12 Nov17     
  Low      
  Medium low     






























Figure 3: Impact evaluation of raw materials including media, media 
supplement, and nutrient feed on TSAC at CCF.   
Figure 4: Comparison of distribution of TSAC at CCF from 
manufacturing cell culture using group I, II, or III of media. 
Figure 5: Comparison of viability trending from manufacturing cell 
culture using group I, II or III of media.  
Figure 6 : Principle component analysis (PCA) 
classifies media lots.  
Table 1: overview of media lot production time and 
corresponding TSAC level.   
Figure 7: Contribution evaluation of media components by 
selectively analyzing media lots resulting in extremely high 












Batches using certain lots of media perform differently in TSAC level 
1. Polynomial model suggests group II media lots result in low level of TSAC 
(Figure 2) 
2. Group II media lots resulting in low TSAC were produced in Mar17- Apr17 
(Table 1)   
3. Multivariate analysis (MVA) suggests that only media groups have the highest 
and significant impact on TSAC, in comparison with media supplement and 
nutrient feed (Figure 3) 
4. Using  group II media lots in manufacturing scale results in statistically 
significant lower TSAC, compared to group I media lots (Figure 4) 
5. Differential viability trending in cell performance is also observed. Batches 
using group II media lots demonstrate the lowest viability trending in 
comparison with other groups (Figure 5).  
Principle Component Analysis (PCA) Classifies Media Lots in the Pattern of 
TSAC Levels.   
1. Levels of trace metals, vitamins, and amino acids of media lots are  included  
in principle component analysis (PCA).  
2. PCA successfully clusters the media lots resulting in low TSAC (Figure  6). 
3. Select media lots resulting in extremely high or low TSAC levels  for 
contribution evaluation. The media lots with extreme TSAC levels are 
indicated by arrows (Figure 7). 
4. Highly ranked factors are prioritized for TSAC evaluation in small scale (2L) 
production bioreactors.  
Low TSAC region 
Expected TSAC region 
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Top Candidate (factor 10) Spiking Experiment to Verify the Effect on TSAC by 
Using 2L Small-Scale-Bioreactors.   
1. PCA and further analysis suggests that the level of factor 10 ( Figure 8) 
could be positively correlated with TSAC level.  
2. Day 7 results show that spiking results in high TSAC level in both duplicates 
3. For day 10 results, one of  the spiking duplicates shows higher TSAC level in 
comparison with its corresponding control, while the other demonstrates a 
similar level between spiking condition and control.   
4. Factor 10 could be one of the root causes but its concentration effect needs 
further evaluation.  
1. Employ multivariate analysis (MVA) to detect potential lots of raw material 
(RM) that cause differential level of TSAC.  
2. Monitor differences of the cell performance by grouping raw material lots 
that result in differential levels of TSAC.  
3. Measure levels of RM components such as trace metals, vitamins, and 
amino acids to be included in principle component analysis (PCA). 
4. Employ PCA to classify RM lots and determine if ithey shares similar patterns 
of TSAC differences.   
5. Evaluate the impact of top candidates suggested by PCA on TSAC in a small 










Figure 1: Schematic of glycosylation in cellular compartments.   
